Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,460,879
  • Shares Outstanding, K 107,650
  • Annual Sales, $ 365,980 K
  • Annual Income, $ 112,510 K
  • 60-Month Beta 0.53
  • Price/Sales 6.88
  • Price/Cash Flow 23.37
  • Price/Book 5.32
Trade CORT with:

Options Overview Details

View History
  • Implied Volatility 34.80% ( -7.18%)
  • Historical Volatility 49.83%
  • IV Percentile 2%
  • IV Rank 8.58%
  • IV High 87.67% on 12/15/21
  • IV Low 29.84% on 11/22/22
  • Put/Call Vol Ratio 0.09
  • Today's Volume 139
  • Volume Avg (30-Day) 345
  • Put/Call OI Ratio 2.80
  • Today's Open Interest 7,092
  • Open Int (30-Day) 8,102

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.15
  • Number of Estimates 3
  • High Estimate 0.22
  • Low Estimate 0.05
  • Prior Year 0.26
  • Growth Rate Est. (year over year) -42.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.53 +4.39%
on 12/06/22
27.38 -14.10%
on 11/16/22
-1.32 (-5.31%)
since 11/07/22
3-Month
22.53 +4.39%
on 12/06/22
30.14 -21.96%
on 11/02/22
-2.81 (-10.67%)
since 09/07/22
52-Week
15.82 +48.63%
on 12/08/21
30.14 -21.96%
on 11/02/22
+1.58 (+7.20%)
since 12/07/21

Most Recent Stories

More News
Corcept (CORT) Up YTD on Robust Korlym Sales, Pipeline Advances

Corcept's (CORT) Cushing's syndrome drug, Korlym, is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.

MRK : 110.09 (+1.06%)
UTHR : 277.08 (+0.17%)
CORT : 23.52 (+2.89%)
CPRX : 16.82 (+2.19%)
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CORT : 23.52 (+2.89%)
UTHR vs. CORT: Which Stock Should Value Investors Buy Now?

UTHR vs. CORT: Which Stock Is the Better Value Option?

UTHR : 277.08 (+0.17%)
CORT : 23.52 (+2.89%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

XPH : 42.37 (+0.71%)
NKTR : 2.91 (unch)
CORT : 23.52 (+2.89%)
AXSM : 78.16 (+3.85%)
IHE : 186.21 (+0.61%)
PPH : 77.63 (-0.31%)
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 42.37 (+0.71%)
NKTR : 2.91 (unch)
CORT : 23.52 (+2.89%)
AXSM : 78.16 (+3.85%)
IHE : 186.21 (+0.61%)
PPH : 77.63 (-0.31%)
3 Biotech Stocks to Accumulate During the Bear Market

2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations...

AMGN : 285.76 (+0.87%)
CORT : 23.52 (+2.89%)
REGN : 764.27 (+2.25%)
Corcept's (CORT) Q3 Earnings Beat Estimates, Revenues Miss

Corcept's (CORT) third-quarter 2022 earnings beat estimates while revenues miss the same. The company tightens its revenue guidance for 2022. Shares down in after-hours trading.

MRK : 110.09 (+1.06%)
JAZZ : 151.10 (+0.78%)
CORT : 23.52 (+2.89%)
CANF : 0.7614 (-2.38%)
Corcept Therapeutics (CORT) Tops Q3 Earnings Estimates

Corcept (CORT) delivered earnings and revenue surprises of 30.43% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CORT : 23.52 (+2.89%)
AFIB : 0.8979 (+16.46%)
Corcept: Q3 Earnings Snapshot

Corcept: Q3 Earnings Snapshot

CORT : 23.52 (+2.89%)
These 3 Stocks Are Winning the Bear Market -- Here's How

Picking the right markets to compete in makes surviving bear markets much more manageable for these companies.

VRTX : 317.58 (+1.85%)
CPRX : 16.82 (+2.19%)
CORT : 23.52 (+2.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 24.68
2nd Resistance Point 24.14
1st Resistance Point 23.83
Last Price 23.52
1st Support Level 22.98
2nd Support Level 22.44
3rd Support Level 22.13

See More

52-Week High 30.14
Fibonacci 61.8% 24.67
Last Price 23.52
Fibonacci 50% 22.98
Fibonacci 38.2% 21.29
52-Week Low 15.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar